Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 9.21M | $ 5.84M | $ 5.28M | $ 4.18M | $ 5.50M |
Total Assets | $ 38.97M | $ 32.81M | $ 30.38M | $ 30.55M | $ 37.38M |
Total Debt | $ 5.16M | $ 2.56M | $ 3.62M | $ 5.63M | $ 5.07M |
Net Debt | $ -4.05M | $ -3.28M | $ -1.66M | $ 1.44M | $ -435.00K |
Total Liabilities | $ 18.61M | $ 14.11M | $ 15.17M | $ 13.92M | $ 14.78M |
Stockholders Equity | $ 20.36M | $ 18.70M | $ 15.21M | $ 16.62M | $ 22.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |